Biosergen AS Cash Flow Reinvestment Rate
Latest as of June 2024:
0.33x
Biosergen AS cash flow reinvestment rate. Biosergen AS (BIOSGN) has a Cash Flow Reinvestment Rate of 0.33x as of June 2024, reinvesting Skr4.41 Million (capex Skr0.00 plus investments Skr-4.41 Million) from operating cash flow of Skr13.45 Million. Explore Biosergen AS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.33x
(Capex + Investments) / Operating CF
Total Reinvested
Skr4.41 Million
Capex + Investments
Operating Cash Flow
Skr13.45 Million
SEK
Capital Expenditures
Skr0.00
SEK
Biosergen AS Cash Flow Reinvestment Rate by Year (None–None)
Biosergen AS cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Biosergen AS. For the full cash flow conversion analysis, see how efficiently does Biosergen AS generate cash.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow